The chemical class known as ZnT-5 inhibitors includes compounds that indirectly influence the activity of the ZnT-5 protein through modulation of zinc homeostasis and related signaling pathways. These inhibitors target various aspects of cellular zinc regulation, from chelation and ionophore-mediated alterations in zinc availability to the competitive inhibition by other metal ions. By affecting the concentration and distribution of zinc within cells, these compounds can modulate the physiological role of ZnT-5 in zinc transport into organelles, impacting processes such as enzymatic activity, protein folding, and gene expression regulated by zinc. The mechanisms by which these compounds operate illustrate the complexity of metal ion homeostasis in cellular biology and underscore the intricate balance required for proper cellular function. For instance, chelators like TPEN and Dithizone can sequester zinc, reducing its availability for transport by ZnT-5 and thus indirectly inhibiting the protein's function. Conversely, compounds like Zinc Pyrithione and Clioquinol may disrupt ZnT-5's role by altering the gradient of zinc concentration that ZnT-5 works against, either by increasing intracellular zinc levels or facilitating its cellular uptake. This bidirectional approach to modulating ZnT-5 activity-either by depleting available zinc or by overwhelming the system with excess zinc-highlights the nuanced strategies for influencing ZnT-5 function.
These compounds provide valuable tools for exploring the role of ZnT-5 in zinc homeostasis and the broader implications of zinc regulation in health and disease. By indirectly modulating the function of ZnT-5, researchers can gain insights into the essential processes regulated by zinc transport and the consequences of disrupting this balance. This exploration extends beyond the specific activity of ZnT-5, offering a window into the complex interplay between metal ions and cellular physiology, and the implications of modulating metal ion transport and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
TPEN | 16858-02-9 | sc-200131 | 100 mg | $130.00 | 10 | |
Zinc chelator, potentially reducing available zinc thus affecting ZnT-5 activity indirectly by altering zinc homeostasis. | ||||||
Dithizone | 60-10-6 | sc-206031A sc-206031 | 10 g 50 g | $92.00 $339.00 | 2 | |
Zinc chelator, could indirectly inhibit ZnT-5 by sequestering zinc and affecting its cellular distribution. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $33.00 $64.00 | 11 | |
NF-kB inhibitor, potentially influencing zinc signaling pathways that indirectly modulate ZnT-5 activity. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Increases zinc concentration, potentially influencing ZnT-5 activity by saturating its transport capacity. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $56.00 $183.00 $352.00 | 1 | |
Cadmium competes with zinc, potentially inhibiting ZnT-5 function by displacing zinc binding. | ||||||
Deferasirox | 201530-41-8 | sc-207509 | 2.5 mg | $180.00 | 9 | |
Iron chelator with affinity for zinc, potentially affecting ZnT-5 function by altering metal ion homeostasis. | ||||||